Astera Labs (NASDAQ:ALAB) Trading 2.4% Higher – Time to Buy?

Astera Labs, Inc. (NASDAQ:ALAB) traded up 2.4% on Friday . The company traded as high as $297.61 and last traded at $291.22. Approximately 2,302,963 shares changed hands during trading, a decline of 56% from the average daily volume of 5,271,240 shares. The stock had previously closed at $284.53.

Analysts Set New Price Targets

ALAB has been the subject of several research analyst reports. TD Cowen reduced their price target on shares of Astera Labs from $425.00 to $375.00 and set a “hold” rating for the company in a report on Wednesday, August 5th. UBS Group reaffirmed a “neutral” rating and issued a $425.00 target price on shares of Astera Labs in a research report on Wednesday, August 5th. Bank of America raised their target price on shares of Astera Labs from $240.00 to $450.00 and gave the company a “neutral” rating in a research note on Tuesday, June 23rd. Northland Securities upgraded shares of Astera Labs from a “market perform” rating to an “outperform” rating and set a $350.00 target price on the stock in a report on Monday, August 17th. Finally, Jefferies Financial Group upped their target price on shares of Astera Labs from $270.00 to $450.00 and gave the company a “buy” rating in a report on Wednesday, August 5th. One research analyst has rated the stock with a Strong Buy rating, twelve have given a Buy rating and eight have issued a Hold rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $348.33.

Astera Labs Trading Up 2.4%

The stock has a market cap of $50.52 billion, a P/E ratio of 144.17 and a beta of 3.77. The stock has a 50 day simple moving average of $316.60 and a 200 day simple moving average of $260.17.

Astera Labs (NASDAQ:ALAB) last posted its quarterly earnings data on Tuesday, August 4th. The company reported $0.80 earnings per share for the quarter, topping the consensus estimate of $0.69 by $0.11. The business had revenue of $392.40 million during the quarter, compared to analysts’ expectations of $360.85 million. Astera Labs had a net margin of 30.74% and a return on equity of 19.24%. Astera Labs’s revenue was up 104.5% compared to the same quarter last year. During the same quarter in the prior year, the business posted $0.44 earnings per share. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. Equities analysts anticipate that Astera Labs, Inc. will post 2.7 earnings per share for the current year.

Insider Buying and Selling at Astera Labs

In related news, Director Manuel Alba sold 183,000 shares of the firm’s stock in a transaction dated Tuesday, September 1st. The stock was sold at an average price of $280.13, for a total value of $51,263,790.00. Following the sale, the director directly owned 253,863 shares of the company’s stock, valued at $71,114,642.19. This trade represents a 41.89% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, General Counsel Philip Mazzara sold 6,801 shares of the stock in a transaction dated Monday, August 17th. The stock was sold at an average price of $340.50, for a total transaction of $2,315,740.50. Following the completion of the transaction, the general counsel directly owned 96,542 shares of the company’s stock, valued at $32,872,551. This trade represents a 6.58% decrease in their position. The SEC filing for this sale provides additional information. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders sold 592,244 shares of company stock worth $209,729,973 over the last quarter. 10.40% of the stock is currently owned by company insiders.

Hedge Funds Weigh In On Astera Labs

Institutional investors and hedge funds have recently added to or reduced their stakes in the business. Greenleaf Trust raised its holdings in shares of Astera Labs by 1.8% during the second quarter. Greenleaf Trust now owns 2,000 shares of the company’s stock valued at $966,000 after purchasing an additional 36 shares during the period. Parkside Financial Bank & Trust grew its stake in shares of Astera Labs by 74.5% in the 2nd quarter. Parkside Financial Bank & Trust now owns 96 shares of the company’s stock valued at $46,000 after buying an additional 41 shares during the period. Glenmede Trust Co. NA increased its position in Astera Labs by 2.7% in the 1st quarter. Glenmede Trust Co. NA now owns 1,909 shares of the company’s stock valued at $209,000 after buying an additional 51 shares in the last quarter. Keating Financial Advisory Services Inc. bought a new stake in shares of Astera Labs during the second quarter valued at approximately $25,000. Finally, Integrated Wealth Concepts LLC lifted its stake in shares of Astera Labs by 0.7% in the second quarter. Integrated Wealth Concepts LLC now owns 7,006 shares of the company’s stock valued at $3,384,000 after buying an additional 52 shares in the last quarter. 60.47% of the stock is currently owned by institutional investors and hedge funds.

About Astera Labs

Astera Labs, Inc is a fabless semiconductor company that develops connectivity solutions for cloud and artificial intelligence infrastructure. Its products are designed to help data-center operators, system manufacturers and other customers connect, expand and manage the high-speed components used in servers, storage systems and networking platforms.

The company’s portfolio includes PCI Express (PCIe) retimers and fabric switches, Compute Express Link (CXL) memory connectivity products, and Ethernet connectivity solutions.